Synapse
⌘+K
Synapse
PulseExploreJournal ClubResearchersJournals
Instagram
HomeJournal ClubExplore
September 10, 2025Journal of Clinical MicrobiologyOpen Access

Emerging technologies for rapid phenotypic antimicrobial susceptibility testing of clinical isolates of bacteria

View Full Paper
Ask AI
Bookmark
Share

Authors

JRJacob RattinMBMalcolm BoswellDRDaniel D. Rhoads

Discussion

Loading...

Member takes

Overview

Minireview highlights emerging rapid AST technologies, showing improved bacterial growth monitoring for better patient care.

Key Points

  • Rapid antimicrobial susceptibility testing can significantly enhance patient care by providing timely results.
  • Current commercial systems for rapid AST utilize novel methods to accurately monitor bacterial growth.
  • The potential of phenotypic RAST lies in its ability to optimize antimicrobial therapies quickly.
  • Implementation of rapid AST systems from clinical specimens shows promise for improving testing efficiency.

Cite This Study

Rattin et al. (2025) studied this question.

synapsesocial.com/papers/68c184069b7b07f3a0610294https://doi.org/10.1128/jcm.00674-25
View Full Paper
Ask AI
Bookmark
Share